Xtant Medical to Issue Third Quarter 2023 Financial Results on November 9, 2023

XTNT Stock  USD 0.40  0.01  2.44%   
Slightly above 61% of Xtant Medical's investor base is looking to short. The analysis of overall sentiment of trading Xtant Medical Holdings stock suggests that many investors are alarmed at this time. Xtant Medical's investing sentiment can be driven by a variety of factors including economic data, Xtant Medical's earnings reports, geopolitical events, and overall market trends.
  
BELGRADE, Mont., Nov. 02, 2023 -- Xtant Medical Holdings, Inc. , a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the third quarter ended September 30, 2023, before the open of the financial markets on Thursday, November 9, 2023. Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a confere

Read at finance.yahoo.com
Yahoo News
  

Xtant Medical Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Xtant Medical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Xtant Medical Fundamental Analysis

We analyze Xtant Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xtant Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xtant Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

EBITDA

EBITDA Comparative Analysis

Xtant Medical is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Xtant Medical Holdings Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Xtant Medical stock to make a market-neutral strategy. Peer analysis of Xtant Medical could also be used in its relative valuation, which is a method of valuing Xtant Medical by comparing valuation metrics with similar companies.

Peers

Xtant Medical Related Equities

MOVEMovano   4.64   
0%
100.0%
SSKNSTRATA Skin   3.96   
0%
85.0%
NPCENeuropace   3.41   
0%
73.0%
FNAParagon 28   3.20   
0%
68.0%
ANIKAnika Therapeutics   3.02   
0%
65.0%
KIDSOrthopediatrics Corp   2.32   
0%
50.0%
OFIXOrthofix Medical   2.09   
0%
45.0%
AORTArtivion   1.62   
0%
34.0%
CVRXCVRx   0.07   
0%
1.0%
LIVNLivaNova PLC   0.04   
0%
1.0%
SRDXSurModics   0.23   
4.0%
0%
ELMDElectromed   0.90   
19.0%
0%
AIMDAinos   2.08   
44.0%
0%
TNONTenon Medical   2.14   
46.0%
0%

Additional Tools for Xtant Stock Analysis

When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.